DAVITA INC. DL -,001/ US23918K1088 /
12/11/2024 08:02:44 | Var. +3.10 | Volume | Denaro16:57:45 | Lettera16:57:45 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
142.10EUR | +2.23% | 0 Fatturato: 0.00 |
146.25Quantità in denaro: 300 | 146.65Quantità in lettera: 300 | 11.92 bill.EUR | - | - |
GlobeNewswire
24/06
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
18/06
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors